A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: pod (42), container (100), case (881), casing (881), shell (12), pill (24)

MyelomaVTDBortezomib(SC)DexamethasoneThalidomideVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA VTD (SC-28)-BORTEZOMIB (SC)-DEXAMETHASONE-THALIDOMIDE (28 day) Regimen Multiple Myeloma – VTD (28)-Bortezomib (SC)-Dexamethasone
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaVTDBortezomibSCDexamethasoneThalidomideVer1.pdf

MyelomaVTDBortezomib(IV)DexamethasoneThalidomideVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA VTD (IV-28)-BORTEZOMIB (IV)-DEXAMETHASONE-THALIDOMIDE (28 day) Regimen Multiple Myeloma – VTD (IV-28)-Bortezomib (IV
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaVTDBortezomibIVDexamethasoneThalidomideVer1.pdf

MyelomaMPTMelphalan(PO)PrednisoloneThalidomideVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA MPT-MELPHALAN (PO)-PREDNISOLONE-THALIDOMIDE Regimen Multiple Myeloma – MPT-Melphalan (PO)-Prednisolone-Thalidomide Indication First line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaMPTMelphalanPOPrednisoloneThalidomideVer1.pdf

MyelomaCTDa28CyclophosphamideDexamethasoneThalidomideAttenuated(CTDa)Ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA CTDa (28)-CYCLOPHOSPHAMIDE-DEXAMETHASONE-THALIDOMIDE (ATTENUATED) (CTDa-28) There are multiple versions of this protocol in use
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaCTDa28CyclophosphamideDexamethasoneThalidomideAttenuatedCTDaVer1.pdf

Whipple's procedure - patient information

Description
Your doctors have recommended that you have an operation called the Whipple's procedure. This is a complex operation to remove part
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Whipples-procedure-3311-PIL.pdf

InP-Etoposide-Ifosfamide (3 day) v2

Description
Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (3 day) Inpatient Regimen Regimen • Sarcoma-InP-Etoposi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Etoposide-Ifosfamide-3-day-v2.pdf

Alectinib

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ALECTINIB Regimen • NSCLC - ALECtinib Indication • Alectinib (as monotherapy) is indicated for first-line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Alectinib.pdf

Cyclophosphamide-Etoposide PO Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-ETOPOSIDE ORAL Regimen Lymphoma – Cyclophosphamide-Etoposide PO Indication Palliative treatment of malignant lymphoma Toxicity Drug Adverse Effect
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Cyclophosphamide-Etoposide-PO-Ver-1.1.pdf

InP Ifosfamide(2day)Ver1

Description
Chemotherapy Protocol SARCOMA IFOSFAMIDE (2 day) Inpatient Regimen Regimen Sarcoma-InP-Ifosfamide (2 day)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPIfosfamide2dayVer1.pdf

Taking oral systemic anti-cancer therapy (SACT) - patient information

Description
This factsheet gives information about taking oral systemic anti-cancer therapy (SACT).
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Taking-oral-systemic-anti-cancer-therapy-SACT-3103-PIL.pdf
61 to 70 of 146
Previous … 5 6 7 8 9 … Next